Psychiatric drug development remains constrained by diagnostic heterogeneity, insufficient and inconsistent drug response, high placebo response rates, and the absence of validated biomarkers that can...

Neuropsychopharmacology - Altered thalamo–prefrontal synchrony dynamics during spatial working memory task performance in a SETD1A loss-of-function mouse model of schizophrenia predisposition

This paper synthesizes insights from a 2026 American College of Neuropsychopharmacology (ACNP) study group examining how to responsibly translate AI into clinical mental health care. Building on this ...

Announcements

The Trump administration has slashed the number of grants from the National Institutes of Health, with far fewer focused on women, cancer and mental health.

YouTube video by NPP - Digital Psychiatry and Neuroscience (DPN)

A substack blog entry from NIH Program Officer Elizabeth Ginexi outlines the sharp discontinuation in the issuance of Notices of Funding Opportunity (NOFO) at the NIH in 2025 and 2026. These NOFO (…

YouTube video by NPP - Digital Psychiatry and Neuroscience (DPN)

Full Committee Hearing on February 3, 2026 at 5:00 AM

Learn which types of projects are better for big team science versus smaller-group support.

The choroid plexus plays an important role in brain health and immunity and may be altered in autism spectrum disorder (ASD). To analyze large imaging datasets, a method to automatically delineate thi...

YouTube video by NPP - Digital Psychiatry and Neuroscience (DPN)

Alt: Alex Trebek saying “okay , here's your question.”

Lieber Institute for Brain Development Appoints Keri Martinowich, Ph.D., as Chief Scientific Officer Baltimore, MD (January 6, 2025) — The Lieber Institute for Brain Development (LIBD) announced the a...